|
Real-time Estimate
Cboe BZX
02:44:53 2026-10-20 pm EDT
|
5-day change | 1st Jan Change | ||
| 5.685 USD | +35.04% |
|
+41.54% | -6.10% |
| 11:04am | Piper Sandler Upgrades Myriad Genetics to Neutral From Underweight, Price Target is $5 | MT |
| 09:29am | Labcorp to Buy Myriad Genetics' Prenatal Health Testing Business for $210 Million | MT |
| Market Cap | 403M 358M 332M 301M 566M 38.15B 575M 3.99B 1.57B 19.96B 1.51B 1.48B 63.69B | P/E 2026 * |
-2.69x | P/E 2027 * | -3.22x |
|---|---|---|---|---|---|
| Enterprise Value | 354M 315M 292M 264M 497M 33.51B 505M 3.5B 1.38B 17.53B 1.33B 1.3B 55.94B | EV / Sales 2026 * |
0.45x | EV / Sales 2027 * | 0.41x |
| Free-Float |
95.99% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MYGN | Delayed | |
CBOE
| MYGN | Real-time | |
|
Börse Stuttgart
| MYD | Delayed | |
|
Boerse Muenchen
| MYD | Real-time | |
|
Tradegate
| MYD | Real-time | |
|
Deutsche Boerse AG
| MYD | Delayed |
Last Transcript: Myriad Genetics, Inc.
| 1 day | +37.89% | ||
| 1 week | +41.54% | ||
| Current month | +33.99% | ||
| 1 month | +44.01% | ||
| 3 months | -2.45% | ||
| 6 months | +12.35% | ||
| Current year | -6.10% |
| 1 week | 3.95 |  | 5.95 |
| 1 month | 3.76 | | 5.95 |
| Current year | 2.74 | | 7.15 |
| 1 year | 2.74 | | 8.5 |
| 3 years | 2.74 | | 29.3 |
| 5 years | 2.74 | | 32.9 |
| 10 years | 2.74 | | 50.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samraat Raha
CEO | Chief Executive Officer | 54 | 2025-04-29 |
Benjamin Wheeler
DFI | Director of Finance/CFO | 43 | 2025-08-15 |
Raj Jampa
CTO | Chief Tech/Sci/R&D Officer | - | 2026-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
S. Phanstiel
CHM | Chairman | 67 | 2020-03-22 |
Heiner Dreismann
BRD | Director/Board Member | 71 | 2010-06-09 |
Colleen Reitan
BRD | Director/Board Member | 66 | 2019-09-24 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/21/26 | Tax | Chief Financial Officer | -2,555 | 0.0027% | ||
| 9/16/26 | Free | Executive/Senior Manager | 257,731 | 0.2695% | ||
| 9/16/26 | Other | Executive/Senior Manager | 93,493 | 0.0977% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +37.17% | +41.54% | -26.90% | -61.68% | 403M | |
| -1.15% | +0.18% | -20.63% | +6.21% | 180B | |
| +1.94% | +1.73% | -1.36% | +30.15% | 114B | |
| +2.27% | +7.87% | -20.05% | +14.71% | 114B | |
| -1.02% | +2.87% | -52.05% | -7.70% | 78.39B | |
| +0.70% | +3.65% | +4.51% | +81.28% | 64.88B | |
| +1.60% | +3.73% | +17.39% | +76.86% | 54.02B | |
| +1.42% | +3.17% | +1.21% | -25.26% | 51.96B | |
| +0.22% | +6.93% | -13.53% | +30.30% | 43.79B | |
| -0.34% | +0.98% | +25.52% | -0.09% | 32.45B | |
| Average | +4.36% | +2.69% | -8.59% | +14.48% | 73.38B | |
| Weighted average by Cap. | +0.56% | +2.97% | -11.89% | +20.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 778M 692M 642M 582M 1.09B 73.69B 1.11B 7.7B 3.02B 38.57B 2.92B 2.86B 123B | 820M 730M 677M 613M 1.15B 77.72B 1.17B 8.12B 3.19B 40.67B 3.08B 3.01B 130B |
| Net income | -140M -124M -115M -104M -196M -13.22B -199M -1.38B -543M -6.92B -524M -513M -22.08B | -106M -94.55M -87.63M -79.4M -149M -10.06B -152M -1.05B -413M -5.27B -398M -390M -16.8B |
| Net Debt | -48.99M -43.6M -40.41M -36.62M -68.82M -4.64B -69.97M -485M -190M -2.43B -184M -180M -7.75B | -67.76M -60.31M -55.9M -50.65M -95.19M -6.42B -96.79M -671M -263M -3.36B -254M -249M -10.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | $5.750 | +36.58% | 20,984,397 |
| 26-10-19 | $4.210 | +5.78% | 1,355,836 |
| 26-10-16 | $3.980 | -8.51% | 1,425,473 |
| 26-10-15 | $4.350 | +4.82% | 1,069,861 |
| 26-10-14 | $4.150 | +1.72% | 1,860,260 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MYGN Stock
Select your edition
All financial news and data tailored to specific country editions
